Vivos Therapeutics Inc. (VVOS)
NASDAQ: VVOS
· Real-Time Price · USD
4.05
-0.56 (-12.15%)
At close: Aug 15, 2025, 11:03 AM
Vivos Therapeutics Fail-to-Deliver
Total FTD Shares
7.9K
Below Average
FTD / Avg. Volume
1.03%
Low Impact
1-Year Change
> 100%
Positive Trend
FTD Chart
As of Jul 14, 2025,
Vivos Therapeutics Inc. has
7,904
shares failed to deliver, representing 1.03%
of the average daily volume of
763,716
shares. Over the past year, the monthly average FTD is
58,932
shares, with the current level 87% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Jul 14, 2025 | 6.95 | 7.9K | +16.03% |
| Jun 30, 2025 | 3.16 | 6.81K | +112.74% |
| May 30, 2025 | 2.42 | 3.2K | +277.15% |
| Apr 29, 2025 | 2.64 | 849 | -64.33% |
| Mar 24, 2025 | 3.71 | 2.38K | +39.67% |
| Feb 28, 2025 | 3.47 | 1.7K | -89.11% |
| Jan 31, 2025 | 3.97 | 15.65K | +5696.30% |
| Dec 30, 2024 | 4.44 | 270 | -82.63% |
| Nov 29, 2024 | 3.41 | 1.55K | -53.25% |
| Oct 31, 2024 | 2.52 | 3.32K | -68.97% |
| Sep 30, 2024 | 2.61 | 10.71K | +2178.94% |
| Aug 30, 2024 | 2.71 | 470 | -85.00% |
| Jul 30, 2024 | 2.18 | 3.13K | -76.56% |
| Jun 28, 2024 | 2.22 | 13.37K | +253.21% |
| May 31, 2024 | 2.09 | 3.79K | +146.58% |
| Apr 30, 2024 | 2.53 | 1.53K | +10864.29% |
| Mar 27, 2024 | 4.65 | 14 | -96.48% |
| Feb 26, 2024 | 4.91 | 398 | -97.84% |
| Jan 31, 2024 | 7.37 | 18.4K | +601.64% |
| Dec 29, 2023 | 12.44 | 2.62K | +432.93% |
| Nov 30, 2023 | 24.5 | 492 | -95.87% |
| Oct 31, 2023 | 3.21 | 11.91K | -49.10% |
| Sep 28, 2023 | 4.55 | 23.39K | +94.54% |
| Aug 10, 2023 | 8.57 | 12.03K | +2777.03% |
| Jul 31, 2023 | 7.28 | 418 | -47.75% |
| Jun 30, 2023 | 12.75 | 800 | -37.16% |
| May 31, 2023 | 9.55 | 1.27K | +403.16% |
| Apr 14, 2023 | 8.35 | 253 | +1165.00% |
| Mar 29, 2023 | 8.25 | 20 | -97.50% |
| Feb 22, 2023 | 18.75 | 800 | +161.44% |
| Jan 30, 2023 | 30.5 | 306 | n/a |